Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sulwhasoo is a premier luxury skincare brand under the Amorepacific umbrella, distinguished by its integration of traditional Korean herbal medicine with modern dermatological science. The company focuses on high-performance cosmeceuticals, particularly those derived from Korean ginseng research, a field they have pioneered since the 1960s. Their proprietary Ginsenomics platform utilizes enzymatic technology to extract rare ginsenosides that offer potent anti-aging and skin-regenerative properties. Sulwhasoo's products, such as the First Care Activating Serum, are globally recognized for their efficacy in improving skin barrier function and vitality. The brand operates at the intersection of luxury beauty and biotechnology, maintaining extensive R&D facilities dedicated to herbal science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sulwhasoo.